{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T12:10:34Z","timestamp":1788351034887,"version":"build-2803163510"},"reference-count":86,"publisher":"FapUNIFESP (SciELO)","issue":"4","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["An. Bras. Dermatol."],"DOI":"10.1590\/abd1806-4841.20199165","type":"journal-article","created":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T22:43:57Z","timestamp":1571352237000},"page":"388-398","source":"Crossref","is-referenced-by-count":42,"title":["Paraneoplastic pemphigus: a clinical, laboratorial, and therapeutic overview"],"prefix":"10.1590","volume":"94","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0541-5526","authenticated-orcid":false,"given":"Celina Wakisaka","family":"Maruta","sequence":"first","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4133-4475","authenticated-orcid":false,"given":"Denise","family":"Miyamoto","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4256-4413","authenticated-orcid":false,"given":"Valeria","family":"Aoki","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2491-4558","authenticated-orcid":false,"given":"Ricardo Gomes Ribeiro de","family":"Carvalho","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2177-0496","authenticated-orcid":false,"given":"Breno Medeiros","family":"Cunha","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3650-4254","authenticated-orcid":false,"given":"Claudia Giuli","family":"Santi","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2019,8]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1056\/NEJM199012203232503","article-title":"Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia","volume":"323","author":"Anhalt GJ","year":"1990","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1046\/j.1523-1747.1998.00449.x","article-title":"Envoplakin and periplakin are components of the paraneoplastic pemphigus antigen complex","volume":"111","author":"Kiyokawa C","year":"1998","journal-title":"J Invest Dermatol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/1523-1747.ep12336235","article-title":"cDNA cloning of the 210-kDa paraneoplastic pemphigus antigen reveals that envoplakin is a component of the antigen complex","volume":"109","author":"Kim SC","year":"1997","journal-title":"J Invest Dermatol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1172\/JCI115781","article-title":"Human autoantibodies against desmoplakins in paraneoplastic pemphigus","volume":"89","author":"Oursler JR","year":"1992","journal-title":"J Clin Invest"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1046\/j.1523-1747.1998.00280.x","article-title":"Autoantibodies from a patient with paraneoplastic pemphigus bind periplakin, a novel member of the plakin family","volume":"111","author":"Borradori L","year":"1998","journal-title":"J Invest Dermatol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1172\/JCI3647","article-title":"Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice","volume":"102","author":"Amagai M","year":"1998","journal-title":"J Clin Invest"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/1523-1747.ep12607012","article-title":"Characterization of paraneoplastic pemphigus autoantigens by immunoblot analysis","volume":"104","author":"Hashimoto T","year":"1995","journal-title":"J Invest Dermatol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/jid.2013.65","article-title":"Anti-\u03b1-2-macroglobulin-like-1 autoantibodies are detected frequently and may be pathogenic in paraneoplastic pemphigus","volume":"133","author":"Numata S","year":"2013","journal-title":"J Invest Dermatol"},{"key":"ref9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012250","article-title":"The protease inhibitor alpha-2-macroglobulin-like-1 is the p170 antigen recognized by paraneoplastic pemphigus autoantibodies in human","volume":"5","author":"Schepens I","year":"2010","journal-title":"PLoS One"},{"key":"ref10","first-page":"193","article-title":"Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus","volume":"137","author":"Nguyen VT","year":"2001","journal-title":"Arch Dermatol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.autrev.2018.04.008","article-title":"Paraneoplastic autoimmune multiorgan syndrome (PAMS): Beyond the single phenotype of paraneoplastic pemphigus","volume":"17","author":"Amber KT","year":"2018","journal-title":"Autoimmun Rev"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/bjd.14234","article-title":"Reply to: Clinical and immunological findings in 104 cases of paraneoplastic pemphigus","volume":"174","author":"Amber KT","year":"2016","journal-title":"Br J Dermatol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"18013","DOI":"10.1038\/nrdp.2018.13","article-title":"Authors' reply: Paraneoplastic autoimmune multi-organ syndrome is a distinct entity from traditional pemphigus subtypes","volume":"4","author":"Payne AS","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"18032","DOI":"10.1038\/nrdp.2018.32","article-title":"Correction: Paraneoplastic autoimmune multiorgan syndrome and paraneoplastic pemphigus describe the same spectrum of disease pathology","volume":"4","author":"Payne AS","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1365-4632.2011.04868.x","article-title":"Paraneoplastic autoimmune multiorgan syndrome: 20 years after","volume":"50","author":"Czernik A","year":"2011","journal-title":"Int J Dermatol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1440-0960.2012.00921.x","article-title":"Paraneoplastic pemphigus","volume":"54","author":"Yong AA","year":"2013","journal-title":"Australas J Dermatol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1046\/j.1365-4362.2001.01169.x","article-title":"Paraneoplastic pemphigus","volume":"40","author":"Kimyai-Asadi A","year":"2001","journal-title":"Int J Dermatol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1046\/j.1365-2133.2002.04992.x","article-title":"Paraneoplastic pemphigus in children and adolescents","volume":"147","author":"Mimouni D","year":"2002","journal-title":"Br J Dermatol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1046\/j.1523-1747.1998.00449.x","article-title":"Envoplakin and periplakin are components of the paraneoplastic pemphigus antigen complex","volume":"111","author":"Kiyokawa C","year":"1998","journal-title":"J Invest Dermatol"},{"key":"ref20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18122532","article-title":"Paraneoplastic pemphigus: insight into the autoimmune pathogenesis, clinical features and therapy","volume":"18","author":"Paolino G","year":"2017","journal-title":"Int J Mol Sci"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"17026","DOI":"10.1038\/nrdp.2017.26","article-title":"Pemphigus","volume":"3","author":"Kasperkiewicz M","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/bjd.13711","article-title":"Anti-desmocollin autoantibodies in nonclassical pemphigus","volume":"173","author":"Ishii N","year":"2015","journal-title":"Br J Dermatol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/j.yexcr.2007.03.039","article-title":"Plakins in development and disease","volume":"313","author":"Sonnenberg A","year":"2007","journal-title":"Exp Cell Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3389\/fmed.2018.00296","article-title":"Diagnosis of autoimmune blistering diseases","volume":"5","author":"Witte M","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1001\/archderm.141.10.1285","article-title":"Paraneoplastic pemphigus associated with Castleman tumor: a commonly reported subtype of paraneoplastic pemphigus in China","volume":"141","author":"Wang J","year":"2005","journal-title":"Arch Dermatol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/sj.jid.5700198","article-title":"Epitopes in the linker subdomain region of envoplakin recognized by autoantibodies in paraneoplastic pemphigus patients","volume":"126","author":"Zhang B","year":"2006","journal-title":"J Invest Dermatol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1523-1747.1999.00520.x","article-title":"Elevated serum levels of interleukin-6 in paraneoplastic pemphigus","volume":"112","author":"Nousari HC","year":"1999","journal-title":"J Invest Dermatol"},{"key":"ref28","first-page":"663","article-title":"Epitope spreading in paraneoplastic pemphigus: autoimmune induction in antibody-mediated blistering skin diseases","volume":"136","author":"Chan LS","year":"2000","journal-title":"Arch Dermatol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1046\/j.1365-2133.1999.03123.x","article-title":"Graft-versus-host disease-like immunophenotype and apoptotic keratinocyte death in paraneoplastic pemphigus","volume":"141","author":"Reich K","year":"1999","journal-title":"Br J Dermatol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0896-8411(02)00092-6","article-title":"Paraneoplastic pemphigus is associated with the DRB1*03 allele","volume":"20","author":"Martel P","year":"2003","journal-title":"J Autoimmun"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2133.2007.08361.x","article-title":"Genotyping of HLA-I and HLA-II alleles in Chinese patients with paraneoplastic pemphigus","volume":"158","author":"Liu Q","year":"2008","journal-title":"Br J Dermatol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1111\/bjd.14162","article-title":"Clinical and immunological findings in 104 cases of paraneoplastic pemphigus","volume":"173","author":"Ohzono A","year":"2015","journal-title":"Br J Dermatol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1346-8138.2012.01655.x","article-title":"Retrospective analysis of 12 Korean patients with paraneoplastic pemphigus","volume":"39","author":"Choi Y","year":"2012","journal-title":"J Dermatol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.clindermatol.2015.11.006","article-title":"Autoimmune bullous diseases with skin and eye involvement: cicatricial pemphigoid, pemphigus vulgaris, and pemphigus paraneoplastica","volume":"34","author":"Broussard KC","year":"2016","journal-title":"Clin Dermatol"},{"key":"ref35","first-page":"644","article-title":"Paraneoplastic pemphigus: a pustular form during chronic lymphoid leukemia","volume":"128","author":"Rivollier C","year":"2001","journal-title":"Ann Dermatol Venereol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0002-9394(14)74494-0","article-title":"Conjunctival involvement in paraneoplastic pemphigus","volume":"114","author":"Meyers SJ","year":"1992","journal-title":"Am J Ophthalmol"},{"key":"ref37","article-title":"Paraneoplastic pemphigus: an uncommon cause of chronic cicatrising conjunctivitis","volume":"2009","author":"Tam PM","year":"2009","journal-title":"BMJ Case Rep"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00432-010-0874-z","article-title":"Improved outcomes after complete resection of underlying tumors for patients with paraneoplastic pemphigus: a single-center experience of 22 cases","volume":"137","author":"Zhang J","year":"2011","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.ad.2017.04.024","article-title":"Paraneoplastic pemphigus. a life-threatening autoimmune blistering disease","volume":"108","author":"Tirado-S\u00e1nchez A","year":"2017","journal-title":"Actas Dermosifiliogr"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.det.2011.03.018","article-title":"Paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome): clinical presentations and pathogenesis","volume":"29","author":"Frew JW","year":"2011","journal-title":"Dermatol Clin"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/ijd.12603","article-title":"Diagnostic imaging in paraneoplastic autoimmune multiorgan syndrome: retrospective single site study and literature review of 225 patients","volume":"54","author":"Lehman VT","year":"2015","journal-title":"Int J Dermatol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1080\/08916930600972099","article-title":"Paraneoplastic autoimmune multiorgan syndrome: review of the literature and support for a cytotoxic role in pathogenesis","volume":"39","author":"Billet SE","year":"2006","journal-title":"Autoimmunity"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"e513","DOI":"10.1542\/peds.2004-0436","article-title":"Paraneoplastic autoimmune multiorgan syndrome (paraneoplastic pemphigus) in a child: case report and review of the literature","volume":"114","author":"Lane JE","year":"2004","journal-title":"Pediatrics"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1016\/j.leukres.2012.04.016","article-title":"Paraneoplastic pemphigus associated with chronic lymphocytic leukaemia: treatment with alemtuzumab","volume":"36","author":"Ekb\u00e4ck M","year":"2012","journal-title":"Leuk Res"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jormas.2018.06.003","article-title":"Buccal paraneoplastic pemphigus multi-resistant: case report and review of diagnostic and therapeutic strategies","volume":"119","author":"Decaux J","year":"2018","journal-title":"J Stomatol Oral Maxillofac Surg"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJM199905063401805","article-title":"The mechanism of respiratory failure in paraneoplastic pemphigus","volume":"340","author":"Nousari HC","year":"1999","journal-title":"N Engl J Med"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1087-0024.2004.00832.x","article-title":"Paraneoplastic pemphigus","volume":"9","author":"Anhalt GJ","year":"2004","journal-title":"J Investig Dermatol Symp Proc"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1080\/10428190903060095","article-title":"Clinical and laboratory characterization of a large cohort of patients with Castleman disease retrospectively collected from a single center","volume":"50","author":"Dong Y","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1378\/chest.117.2.603","article-title":"Paraneoplastic pemphigus associated with bronchiolitis obliterans","volume":"117","author":"Takahashi M","year":"2000","journal-title":"Chest"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1001\/archderm.1992.01680180085011","article-title":"Histologic features of paraneoplastic pemphigus","volume":"128","author":"Horn TD","year":"1992","journal-title":"Arch Dermatol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1067\/mjd.2000.107488","article-title":"Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus","volume":"43","author":"Joly P","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0190-9622(95)90066-7","article-title":"Accuracy of indirect immunofluorescence testing in the diagnosis of paraneoplastic pemphigus","volume":"32","author":"Helou J","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/bjd.14282","article-title":"Direct and indirect immunofluorescence staining patterns in the diagnosis of paraneoplastic pemphigus","volume":"174","author":"Poot AM","year":"2016","journal-title":"Br J Dermatol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0190-9622(93)70095-B","article-title":"Indirect immunofluorescence on rat bladder transitional epithelium: a test with high specificity for paraneoplastic pemphigus","volume":"28","author":"Liu AY","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jaad.2003.11.051","article-title":"Mucosal dominant pemphigus vulgaris with anti-desmoplakin autoantibodies","volume":"51","author":"Mimouni D","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1590\/S1807-59322011001200004","article-title":"Analysis of the reactivity of indirect immunofluorescence in patients with pemphigus foliaceus and pemphigus vulgaris using rat bladder epithelium as a substrate","volume":"66","author":"Ortolan DG","year":"2011","journal-title":"Clinics (Sao Paulo)"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1046\/j.1523-1747.1998.00279.x","article-title":"The members of the plakin family of proteins recognized by paraneoplastic pemphigus antibodies include periplakin","volume":"111","author":"Mahoney MG","year":"1998","journal-title":"J Invest Dermatol"},{"key":"ref58","first-page":"563","article-title":"Auto-immune bullous diseases autoantibodies (pemphigus, bullous pemphigoid): what the dermatologist must know","volume":"140","author":"Ingen-Housz-Oro S","year":"2013","journal-title":"Ann Dermatol Venereol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/bjd.12479","article-title":"Laboratory diagnosis of paraneoplastic pemphigus","volume":"169","author":"Poot AM","year":"2013","journal-title":"Br J Dermatol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2340\/00015555-1742","article-title":"A typical case of paraneoplastic pemphigus without detection of malignancy: effectiveness of plasma exchange","volume":"94","author":"Kitagawa C","year":"2014","journal-title":"Acta Derm Venereol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/bjd.14293","article-title":"A case of paraneoplastic pemphigus associated with Castleman disease reacting with multiple autoantigens, including the p200 protein","volume":"174","author":"Oh SJ","year":"2016","journal-title":"Br J Dermatol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1001\/archdermatol.2012.1830","article-title":"Prognostic factors of paraneoplastic pemphigus","volume":"148","author":"Leger S","year":"2012","journal-title":"Arch Dermatol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0140-6736(04)15539-6","article-title":"Castleman's tumours and production of autoantibody in paraneoplastic pemphigus","volume":"363","author":"Wang L","year":"2004","journal-title":"Lancet"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1365-2133.2005.06599.x","article-title":"Autoantibody production from a thymoma and a follicular dendritic cell sarcoma associated with paraneoplastic pemphigus","volume":"153","author":"Wang J","year":"2005","journal-title":"Br J Dermatol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/bjd.13525","article-title":"Prevalence of myasthenia gravis and associated autoantibodies in paraneoplastic pemphigus and their correlations with symptoms and prognosis","volume":"172","author":"Wang R","year":"2015","journal-title":"Br J Dermatol"},{"key":"ref66","first-page":"1006","article-title":"The significance of titin antibodies in myasthenia gravis \u00ac- correlation with thymoma and severity of myasthenia gravis","volume":"251","author":"Chen XJ","year":"2004","journal-title":"J Neurol"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1468-1331.2007.01785.x","article-title":"Myasthenia gravis patients with ryanodine receptor antibodies have distinctive clinical features","volume":"14","author":"Romi F","year":"2007","journal-title":"Eur J Neurol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/JID.2015.408","article-title":"Epiplakin is a paraneoplastic pemphigus autoantigen and related to bronchiolitis obliterans in Japanese patients","volume":"136","author":"Tsuchisaka A","year":"2016","journal-title":"J Invest Dermatol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/scd.12093","article-title":"The importance of multidisciplinary healthcare for paraneoplastic pemphigus","volume":"35","author":"Al Zamel G","year":"2015","journal-title":"Spec Care Dentist"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.det.2011.06.016","article-title":"Current management strategies in paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome)","volume":"29","author":"Frew JW","year":"2011","journal-title":"Dermatol Clin"},{"key":"ref71","first-page":"24","article-title":"Practical management of immunosuppressants in dermatology","volume":"109","author":"Leis-Dosil VM","year":"2018","journal-title":"Actas Dermosifiliogr"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.clindermatol.2009.06.018","article-title":"Adjuvant drugs in autoimmune bullous diseases, efficacy versus safety: facts and controversies","volume":"28","author":"Schiavo AL","year":"2010","journal-title":"Clin Dermatol"},{"key":"ref73","first-page":"833","article-title":"S2k guidelines for the treatment of pemphigus vulgaris\/foliaceus and bullous pemphigoid","volume":"13","author":"Eming R","year":"2015","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1046\/j.1365-2133.2000.03365.x","article-title":"Use of mycophenolate mofetil in the treatment of paraneoplastic pemphigus","volume":"142","author":"Williams JV","year":"2000","journal-title":"Br J Dermatol"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0025-6196(12)61787-X","article-title":"Paraneoplastic pemphigus: a case of prolonged survival","volume":"69","author":"Perniciaro C","year":"1994","journal-title":"Mayo Clin Proc"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/j.1365-4632.2006.02796.x","article-title":"Paraneoplastic pemphigus resembling linear IgA bullous dermatosis","volume":"45","author":"Lee JS","year":"2006","journal-title":"Int J Dermatol"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1586\/1744666X.4.3.351","article-title":"Rationale and efficacy for the use of rituximab in paraneoplastic pemphigus","volume":"4","author":"Vezzoli P","year":"2008","journal-title":"Expert Rev Clin Immunol"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/1096-8652(200102)66:2<142::AID-AJH1032>3.0.CO;2-0","article-title":"Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL","volume":"66","author":"Heizmann M","year":"2001","journal-title":"Am J Hematol"},{"key":"ref79","first-page":"269","article-title":"Anti-CD20 monoclonal antibody (rituximab) for refractory erosive stomatitis secondary to CD20(+) follicular lymphoma-associated paraneoplastic pemphigus","volume":"137","author":"Borradori L","year":"2001","journal-title":"Arch Dermatol"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/1346-8138.12095","article-title":"Case of paraneoplastic pemphigus with follicular lymphoma treated with rituximab","volume":"40","author":"Aoi J","year":"2013","journal-title":"J Dermatol"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1468-3083.2005.01345.x","article-title":"Therapy of paraneoplastic pemphigus with rituximab: a case report and review of literature","volume":"20","author":"Barnadas M","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/1346-8138.13160","article-title":"Paraneoplastic pemphigus associated with fatal bronchiolitis obliterans and intractable mucosal erosions: Treatment with cyclosporin in addition to steroid, rituximab and intravenous immunoglobulin","volume":"43","author":"Namba C","year":"2016","journal-title":"J Dermatol"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1111\/jdv.14500","article-title":"Paraneoplastic pemphigus seen in four patients with haematological malignancies formerly treated with rituximab","volume":"32","author":"Baykal C","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1600-0609.2004.00280.x","article-title":"Alemtuzumab-induced remission of both severe paraneoplastic pemphigus and leukaemic bone marrow infiltration in a case of treatment-resistant B-cell chronic lymphocytic leukaemia","volume":"73","author":"Hohwy T","year":"2004","journal-title":"Eur J Haematol"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/bjd.12324","article-title":"Alemtuzumab is effective against severe chronic lymphocytic leukaemia-associated paraneoplastic pemphigus","volume":"169","author":"Bech R","year":"2013","journal-title":"Br J Dermatol"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1365-2230.2011.04081.x","article-title":"Successful treatment of a paraneoplastic pemphigus in a teenager using plasmapheresis, corticosteroids and tumour resection","volume":"36","author":"Jing L","year":"2011","journal-title":"Clin Exp Dermatol"}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/abd\/v94n4\/0365-0596-abd-94-04-0388.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T15:00:46Z","timestamp":1747666846000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0365-05962019000400388&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":86,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,8]]}},"alternative-id":["S0365-05962019000400388"],"URL":"https:\/\/doi.org\/10.1590\/abd1806-4841.20199165","relation":{},"ISSN":["1806-4841","0365-0596"],"issn-type":[{"value":"1806-4841","type":"electronic"},{"value":"0365-0596","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]}}}